Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Witjes

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Pharmacokinetics and Pharmacodynamics|April 26, 2019
Operating characteristics of stepwise covariate selection in pharmacometric modelingMalidi Ahamadi, Anna Largajolli, Paul M Diderichsen, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 16, 2023
Characterizing the exposure-response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myelomaJamie N Connarn, Han Witjes, Marielle van Zutphen-van Geffen, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2019
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal DosingJos Lommerse, Diana Clarke, Thomas Kerbusch, et al.
Journal of Clinical Pharmacology|November 14, 2018
Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With PreeclampsiaLihong Du, Larissa Wenning, Elizabeth Migoya, et al.
Journal of Clinical Pharmacology|June 4, 2019
Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure-Response Modeling and Simulation StudyLihong Du, Larissa A Wenning, Brendan Carvalho, et al.
Clinical and Translational Science|February 10, 2026
An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid TumorsJatinder Kaur Mukker, Timothy A Yap, Anthony W Tolcher, et al.
Ebiomedicine|November 14, 2021
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxisBrian M Maas, Jos Lommerse, Nele Plock, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Pharmacokinetics and Pharmacodynamics|April 26, 2019
Operating characteristics of stepwise covariate selection in pharmacometric modelingMalidi Ahamadi, Anna Largajolli, Paul M Diderichsen, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 16, 2023
Characterizing the exposure-response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myelomaJamie N Connarn, Han Witjes, Marielle van Zutphen-van Geffen, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2019
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal DosingJos Lommerse, Diana Clarke, Thomas Kerbusch, et al.
Journal of Clinical Pharmacology|November 14, 2018
Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With PreeclampsiaLihong Du, Larissa Wenning, Elizabeth Migoya, et al.
Journal of Clinical Pharmacology|June 4, 2019
Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure-Response Modeling and Simulation StudyLihong Du, Larissa A Wenning, Brendan Carvalho, et al.
Clinical and Translational Science|February 10, 2026
An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid TumorsJatinder Kaur Mukker, Timothy A Yap, Anthony W Tolcher, et al.
Ebiomedicine|November 14, 2021
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxisBrian M Maas, Jos Lommerse, Nele Plock, et al.
Pageof 3